TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive In Brief: Marks’ Appointment As President, Chief Executive Officer Of Memorial Sloan-Kettering, Official June 27, 1980